ArticleChest2022

COVID-19 in Lymphangioleiomyomatosis: An International Study of Outcomes and Impact of Mechanistic Target of Rapamycin Inhibition.

Bruno Guedes Baldi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.